Ke Zhao
State Key Laboratory Of Medical Proteomics
Beijing, 100850, China
Beijing, 100850, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Effects of prolonged exposure to 2.45 GHz electromagnetic fields on mouse health over a 5-month period.
Journal: Ecotoxicology and environmental safety
Published: November 15, 2025
Nonthermal radiofrequency radiation promotes hematopoietic stem and progenitor cells function by regulating Ca2+ efflux.
Journal: Stem cell research & therapy
Published: October 23, 2025
USP13 stabilizes NLRP3 to facilitate inflammasome activation by preventing TRIM31-mediated NLRP3 ubiquitination and degradation.
Journal: Science advances
Published: September 26, 2025
GPS2 regulates embryonic angiogenesis by enhancing endothelial cell survival through stabilizing HOIP.
Journal: Cell death and differentiation
Published: February 14, 2025
BRISC inactivation alleviates alcohol-induced liver injury in mice.
Journal: Scientific reports
Published: October 22, 2024
Single-Cell Transcriptomics Reveals Early Effects of Ionizing Radiation on Bone Marrow Mononuclear Cells in Mice.
Journal: International journal of molecular sciences
Published: July 01, 2024
GPS2 promotes erythroid differentiation in K562 erythroleukemia cells primarily via NCOR1.
Journal: International journal of hematology
Published: November 22, 2023
ExpressVis: a biologist-oriented interactive web server for exploring multi-omics data.
Journal: Nucleic acids research
Published: March 19, 2022
Hemgn Protects Hematopoietic Stem and Progenitor Cells Against Transplantation Stress Through Negatively Regulating IFN-γ Signaling.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 01, 2021
Protein phosphatase 2A catalytic subunit β suppresses PMA/ionomycin-induced T-cell activation by negatively regulating PI3K/Akt signaling.
Journal: The FEBS journal
Published: August 19, 2021
Preclinical Pharmacokinetics, Tissue Distribution, and Primary Safety Evaluation of Indo5, a Novel Selective Inhibitor of c-Met and Trks.
Journal: Frontiers in pharmacology
Published: May 18, 2021
Last Updated: 09/26/2026